Advertisement

Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth

      Abstract

      Introduction

      Visfatin is a recently identified adipokine with numerous metabolic and immunoregulatory properties that has been implicated in the regulation of the white adipose tissue (WAT) and significant changes in visfatin levels were reported during pregnancy. The aim of the study was to investigate dynamics of visfatin levels in maternal serum and human breast milk during a 180-d period after the delivery.

      Materials and methods

      : Breast milk and venous blood samples were obtained from 24 healthy lactating women with uncomplicated, physiological pregnancy and appropriate-for-gestational age neonates and serum–milk sample duos were collected at the time of birth, at the 1–3, 12–14, 28–30, 88–90 and 178–180 postpartum.

      Results

      Our study demonstrates that (1) visfatin is abundantly secreted into breast milk in humans, reaching approx. 100× higher concentrations compared to maternal serum; (2) visfatin concentrations in maternal serum show significant variations after the delivery and (3) visfatin concentration in colostrum could be used for prediction of the subsequent weight development (less/more severe weight loss during first 3 days after the birth) of the infant.

      Discussion

      Our data suggest that visfatin could play an important role in regulation of adiposity of the infatn after the birth.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Trayhurn P.
        • Wood I.S.
        Signalling role of adipose tissue: adipokines and inflammation in obesity.
        Biochem Soc Trans. 2007; 33: 1078-1081
        • Ronti T.
        • Lupattelli G.
        • Mannarino E.
        The endocrine function of adipose tissue: an update.
        Clin Endocrinol (Oxf). 2006; 64: 355-365
      1. Vigh E, Bódis J, Garai J. Longitudinal changes in macrophage migration inhibitory factor in breast milk during the first three months of lactation. J Reprod Immunol 2011 [epub ahead of print].

        • Garofalo R.
        Cytokines in human milk.
        J Pediatr. 2010; 156: S36-40
        • Hanson L.A.
        Session 1: feeding and infant development breast-feeding and immune function.
        Proc Nutr Soc. 2007; 66: 384-396
        • Ballabio C.
        • Bertino E.
        • Coscia A.
        • Fabris C.
        • Fuggetta D.
        • Molfino S.
        • et al.
        Immunoglobulin-A profile in breast milk from mothers delivering full term and preterm infants.
        Int J Immunopathol Pharmacol. 2007; 20: 119-128
        • Zimmer J.P.
        • Garza C.
        • Heller M.E.
        • Butte N.
        • Goldman A.S.
        Relationship between serum prolactin, lactation and changes in maternal blood B-cell (CD19+) percents during the first 8 months post-partum.
        J Reprod Immunol. 1996; 30: 81-95
        • Samal B.
        • Sun Y.
        • Stearns G.
        • Xie C.
        • Suggs S.
        • McNiece I.
        Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.
        Mol Cell Biol. 1994; 14: 1431-1437
        • Luk T.
        • Malam Z.
        • Marshall J.C.
        Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.
        J Leukoc Biol. 2008; 83: 804-816
        • Nemeth E.
        • Millar L.K.
        • Bryant-Greenwood G.
        Fetal membrane distention. II. Differentially expressed genes regulated by acute distention in vitro.
        Am J Obstet Gynecol. 2000; 182: 60-67
        • Mazaki-Tovi S.
        • Romero R.
        • Kusanovic J.P.
        • Erez O.
        • Gotsch F.
        • et al.
        Visfatin/pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition.
        J Perinat Med. 2008; 36: 485-496
        • Xu L.G.
        • Wu M.
        • Hu J.
        • Zhai Z.
        • Shu H.B.
        Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1.
        J Leukoc Biol. 2002; 72: 410-416
        • Patrone L.
        • Damore M.A.
        • Lee M.B.
        • Malone C.S.
        • Wall R.
        Genes expressed during the IFN gamma-induced maturation of pre-B cells.
        Mol Immunol. 2002 Jan; 38: 597-606
        • Folgueira M.A.
        • Carraro D.M.
        • Brentani H.
        • Patrão D.F.
        • Barbosa E.M.
        • et al.
        Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.
        Clin Cancer Res. 2005; 11: 7434-7443
        • Bae S.K.
        • Kim S.R.
        • Kim J.G.
        • Kim J.Y.
        • Koo T.H.
        • Jang H.O.
        • et al.
        Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1.
        FEBS Lett. 2006; 580: 4105-4113
        • Yonezawa T.
        • Haga S.
        • Kobayashi Y.
        • Takahashi T.
        • Obara Y.
        Visfatin is present in bovine mammary epithelial cells, lactating mammary gland and milk, and its expression is regulated by cAMP pathway.
        FEBS Lett. 2006; 580: 6635-6643
      2. Prevention of diabetes mellitus. Report of a WHO study group. World Health Organ Tech Rep Ser 1994;844:1–100.

        • Bronsky J.
        • Mitrova K.
        • Karpisek M.
        • Mazoch J.
        • Durilova M.
        • Fisarkova B.
        • et al.
        Adiponectin, AFABP, and leptin in human breast milk during 12 months of lactation.
        J Pediatr Gastroenterol Nutr. 2011; 52: 474-477
        • Ilcol Y.O.
        • Hizli Z.B.
        • Ozkan T.
        Leptin concentration in breast milk and its relationship to duration of lactation and hormonal status.
        Int Breastfeed J. 2006; 17: 21
        • Savino F.
        • Liguori S.A.
        • Petrucci E.
        • Lupica M.M.
        • Fissore M.F.
        • Oggero R.
        • et al.
        Evaluation of leptin in breast milk, lactating mothers and their infants.
        Eur J Clin Nutr. 2010; 64: 972-977
        • Moschen A.R.
        • Gerner R.R.
        • Tilg H.
        Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders.
        Curr Pharm Des. 2010; 16: 1913-1920
        • Lemor A.
        • Hosseini A.
        • Sauerwein H.
        • Mielenz M.
        Transition period-related changes in the abundance of the mRNAs of adiponectin and its receptors, of visfatin, and of fatty acid binding receptors in adipose tissue of high-yielding dairy cows.
        Domest Anim Endocrinol. 2009; 37: 37-44
        • Coskun A.
        • Ozkaya M.
        • Kiran G.
        • Kilinc M.
        • Arikan D.C.
        Plasma visfatin levels in pregnant women with normal glucose tolerance, gestational diabetes and pre-gestational diabetes mellitus.
        J Matern Fetal Neonatal Med. 2010; 23: 1014-1018
        • Zulfikaroglu E.
        • Isman F.
        • Payasli A.
        • Kilic S.
        • Kucur M.
        • Danisman N.
        Plasma visfatin levels in preeclamptic and normal pregnancies.
        Arch Gynecol Obstet. 2010; 281: 995-998
        • Mazaki-Tovi S.
        • Romero R.
        • Vaisbuch E.
        • Erez O.
        • Chaiworapongsa T.
        • Mittal P.
        • et al.
        Maternal plasma visfatin in preterm labor.
        J Matern Fetal Neonatal Med. 2009; 22: 693-704
        • Ferreira A.F.
        • Rezende J.C.
        • Vaikousi E.
        • Akolekar R.
        • Nicolaides K.H.
        Maternal serum visfatin at 11–13 weeks of gestation in gestational diabetes mellitus.
        Clin Chem. 2011; 57: 609-613
        • Ma Y.
        • Cheng Y.
        • Wang J.
        • Cheng H.
        • Zhou S.
        • Li X.
        The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes.
        Diabetes Res Clin Pract. 2010; 90: 60-65
        • Mazaki-Tovi S.
        • Vaisbuch E.
        • Romero R.
        • Kusanovic J.P.
        • Chaiworapongsa T.
        • Kim S.K.
        • et al.
        Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis.
        Am J Reprod Immunol. 2010; 63: 252-262
        • Mazaki-Tovi S.
        • Romero R.
        • Vaisbuch E.
        • Kim S.K.
        • Kusanovic J.P.
        • Chaiworapongsa T.
        • et al.
        Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartments in normal spontaneous labor at term.
        J Perinat Med. 2010 May; 38: 281-288
        • Mazaki-Tovi S.
        • Vaisbuch E.
        • Romero R.
        • Kusanovic J.P.
        • Chaiworapongsa T.
        • Kim S.K.
        • et al.
        Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate.
        J Matern Fetal Neonatal Med. 2010; 23: 1119-1128
        • Sun Q.
        • Li L.
        • Li R.
        • Yang M.
        • Liu H.
        • Nowicki M.J.
        • et al.
        Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats.
        Ann Med. 2009; 41: 311-320
        • Zhou J.
        • Seidel E.R.
        Estrogens induce visfatin expression in 3T3-L1 cells.
        Peptides. 2010 Feb; 31: 271-274